not sure why any major Pharma will do a deal now when they could wait for outcome of FUTILITY analysis in march.
//if the futility threshold is not met, it's game over, study immediately dead. that's what is meant by futility and how futility is set up.
//if futility threshold is met, that's good and OK but doesn't tell you the study will achieve its endpoints, it just tells you there's something here and it's worth continuing trial.
so my strategy is to wait for that outcome and if it passes futility threshold I want to see how comfortably it did it, then will considering buying
I can't find anywhere if dimerx has ever mentioned the futility threshold, kinda useful to know
not sure why any major Pharma will do a deal now when they could...
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
-0.015(2.63%) |
Mkt cap ! $305.1M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 58.5¢ | 54.0¢ | $3.231M | 5.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1118 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 239062 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |